Swollen tongue; sore throat; difficulty breathing; chest pain; nasal congestion; headache; fever; muscle pain; lethargy; nausea; lower abdominal pain; lower back pain; cold hands and feet; light sensitivity; sleepy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 13:45 (Lot number: EW0186) at the age of 52 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "chronic fatigue" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "allergies" (unspecified if ongoing); "allergies: gluten" (unspecified if ongoing); "allergies: diary intolerance" (unspecified if ongoing); "allergies: allergic to broccoli" (unspecified if ongoing); "allergies: allergic to mushroom" (unspecified if ongoing); "allergies: allergic to cleaning chemicals" (unspecified if ongoing). Concomitant medication(s) included: ZOLPIDEM; ARMOUR THYROID; TYLENOL; VITAMIN C ACID; VIT D [VITAMIN D NOS]. Past drug history included: Vicodin, reaction(s): "Allergies: Vicodin"; Codeine, reaction(s): "Allergies: codeine". Vaccination history included: Bnt162b2 (Product COVID 19, Brand: Pfizer, Lot number: EW0172, Lot unknown: False, Administration date:19Jul2021, Administration time: 01:45 PM, Dose number:1, Vaccine location: Right arm), administration date: 19Jul2021, when the patient was 52 years old, for COVID-19 Immunization. The following information was reported: SWOLLEN TONGUE (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "Swollen tongue"; OROPHARYNGEAL PAIN (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "sore throat"; DYSPNOEA (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "difficulty breathing"; CHEST PAIN (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "chest pain"; NASAL CONGESTION (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "nasal congestion"; HEADACHE (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "headache"; PYREXIA (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "fever"; MYALGIA (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "muscle pain"; LETHARGY (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "lethargy"; NAUSEA (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "nausea"; ABDOMINAL PAIN LOWER (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "lower abdominal pain"; BACK PAIN (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "lower back pain"; PERIPHERAL COLDNESS (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "cold hands and feet"; PHOTOPHOBIA (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "light sensitivity"; SOMNOLENCE (non-serious) with onset 16Aug2021 14:15, outcome "recovering", described as "sleepy". Therapeutic measures were not taken as a result of swollen tongue, oropharyngeal pain, dyspnoea, chest pain, nasal congestion, headache, pyrexia, myalgia, lethargy, nausea, abdominal pain lower, back pain, peripheral coldness, photophobia, somnolence.  Additional Information: Report about Covid vaccine: Yes, Lot unknown: False for dose 2, Lot unknown: False for dose 1. Facility type vaccine: Doctor's office/urgent care . If other vaccine in four weeks: No. If covid prior vaccination: No. If covid tested post vaccination: No     No follow-up attempts are possible. No further information is expected.